GR-891: a novel 5-fluorouracil acyclonucleoside prodrug for differentiation therapy in rhabdomyosarcoma cells

Differentiation therapy provides an alternative treatment of cancer that overcomes the undesirable effects of classical chemotherapy, i.e. cytotoxicity and resistance to drugs. This new approach to cancer therapy focuses on the development of specific agents designed to selectively engage the proces...

Descripción completa

Detalles Bibliográficos
Autores principales: Marchal, J A, Prados, J, Melguizo, C, Gómez, J A, Campos, J, Gallo, M A, Espinosa, A, Arena, N, Aránega, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362655/
https://www.ncbi.nlm.nih.gov/pubmed/10070873
http://dx.doi.org/10.1038/sj.bjc.6690129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362655/
https://www.ncbi.nlm.nih.gov/pubmed/10070873
http://dx.doi.org/10.1038/sj.bjc.6690129

Ejemplares similares